[1] Sarin SK,Kedarisetty CK,Abbas Z,et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int,2014,8:453-471.
[2] Duseja A,Singh SP. Toward a better definition of acute-on-chronic liver failure. J Clin Exp Hepatol,2017,7:262-265.
[3] Gulsen M,Yesilova Z,Bagci S,et al. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol,2005,20:1448-1455.
[4] 吴荣芳,李福康. 不同同型半胱氨酸水平对乙肝肝硬化患者预后的影响观察. 中国中西医结合消化杂志,2017,25:344-347.
[5] 谭立明,蒙仪妹,隆婷婷,等. 降钙素原、D-二聚体、C-反应蛋白对慢加急性肝衰竭患者并发感染的临床意义. 实用医学杂志,2018,34:410-415.
[6] 中华医学会感染病学会分会,中华医学会肝病学分会. 肝衰竭诊治指南(2012版). 中华肝脏病杂志,2013,21:177-183.
[7] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年更新版). 临床肝胆病杂志,2015,31:1941-1960.
[8] Freeman RB Jr,Wiesner RH,Harper A,et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl,2002,8:851-858.
[9] 王瑞锋,尹娟. 同型半胱氨酸与肝炎严重程度的相关性研究. 中国临床新医学,2017,10:794-797.
[10] 杨焦峰,王伟娟,康丽霞,等. 血清降钙素原和C反应蛋白在细菌感染性疾病诊断中的价值. 新乡医学院学报,2015,32:233-234.
[11] 李华. MELD评分联合血清降钙素原评估乙型肝炎相关慢加急性肝衰竭患者短期预后的价值. 肝脏,2017,22:210-213.
[12] 梁敏锋,周惠玲,郑雪英,等. MELD评分结合血清降钙素原评价乙型肝炎相关慢加急性肝衰竭患者短期预后的价值. 深圳中西医结合杂志,2017,27:7-9. |
